Tricia Brooks

Tricia is a dynamic public affairs strategist and thought leader with 30 years’ experience in advocacy, lobbying, policy development and communications leading to outcomes beneficial to both patients and the healthcare enterprise. She has a proven track record in cultivating alliances; advancing federal and state advocacy agendas; and developing, leading and motivating high-performing teams. At Eisai, Tricia and her team have navigated new and unparalleled policy questions while also working to transform care delivery for patients and their care-partners. As VP of External Affairs, Tricia drove ACHP’s role in transforming the healthcare sector through proactive legislative and regulatory solutions that fostered high-quality, affordable coverage and care to beneficiaries. During her tenure at Novo Nordisk, Tricia led a team of 30+ highly collaborative individuals to improve patient care and achieve business goals by optimizing credibility, reach, and impact, and by building alliances with internal and external stakeholders. Prior, as Managing Director, Alliance Development for BIO, she built alliances between the health advocacy community and bio-pharma, leading to positive policy outcomes such as supporting/maintaining 12 years exclusivity for biosimilars and eliminating insurance life-time caps. She also promoted investment opportunities via the Venture Philanthropy model. Earlier, as Principal, WHD Government Affairs, Tricia developed and implemented government relations strategies, represented clients’ voice to external stakeholders and worked to increase Congressional support for federal funding of embryonic stem cell research. As Director, Government Relations for the Christopher & Dana Reeve Foundation, she spearheaded writing and lobbying for the Christopher and Dana Reeve Paralysis Act. Tricia holds a Bachelor of Arts degree from Fordham University, and a Master of Arts degree from The George Washington University.